The popular weight-loss drug Zepbound can now be used to treat sleep apnea - USA Today
FDA approves Eli Lilly's Zepbound for moderate-to-severe sleep apnea and obesity, marking the first medication for obstructive sleep apnea. Zepbound, a GLP-1 drug, should be used with a reduced-calorie diet and increased physical activity. Studies show it reduces breathing pauses and promotes weight loss, though side effects include nausea and stomach discomfort. Concerns over GLP-1 medication prices persist.
Highlighted Terms
Related News
FDA approves Eli Lilly's Zepbound for moderate-to-severe sleep apnea and obesity, marking the first medication for obstructive sleep apnea. Zepbound, a GLP-1 drug, should be used with a reduced-calorie diet and increased physical activity. Studies show it reduces breathing pauses and promotes weight loss, though side effects include nausea and stomach discomfort. Concerns over GLP-1 medication prices persist.